APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Digestive System Disease Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Digestive System Disease Treatment Market Analysis and Forecast 2026-2032

Report ID 173984700223 December 2025210 pages

Choose your research edition.

Industry ResearchDigestive System Disease Treatment Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Digestive System Disease Treatment Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Digestive System Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digestive System Disease Treatment Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Digestive System Disease Treatment Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Digestive System Disease Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Digestive System Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Digestive System Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Digestive System Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Digestive System Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Digestive System Disease Treatment include Zhengdatianqing Pharma, Takeda Pharma, Eisai Co., Teva, Sun Pharma, Shanghai Shangyao, Sanofi, Luoxin Pharma and LIVZON, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Digestive System Disease Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Digestive System Disease Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Digestive System Disease Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Digestive System Disease Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Digestive System Disease Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Digestive System Disease Treatment revenue, projected growth trends, production technology, application and end-user industry.

Digestive System Disease Treatment Segment by Company

Zhengdatianqing Pharma

Takeda Pharma

Eisai Co.

Teva

Sun Pharma

Shanghai Shangyao

Sanofi

Luoxin Pharma

LIVZON

Pfizer

Eastchina Pharma

Bayer

AbbVie

AstraZeneca

Zydus Cadila

Viatris

Intercept

Heron Therapeutics

Dr Falk Pharma

Bausch Health

AOSAIKANG Pharma

Digestive System Disease Treatment Segment by Type

Injection

Tablet

Caspuse

Other

Digestive System Disease Treatment Segment by Application

Hospital

Retail Pharmacy

Other

Digestive System Disease Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digestive System Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digestive System Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digestive System Disease Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Digestive System Disease Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Digestive System Disease Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digestive System Disease Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Digestive System Disease Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Player Table 3. Tablet Major Player Table 4. Caspuse Major Player Table 5. Other Major Player Table 6. Global Digestive System Disease Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Retail Pharmacy Major Player Table 9. Other Major Player Table 10. Digestive System Disease Treatment Industry Trends Table 11. Digestive System Disease Treatment Industry Drivers Table 12. Digestive System Disease Treatment Industry Opportunities and Challenges Table 13. Digestive System Disease Treatment Industry Restraints Table 14. Global Digestive System Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Digestive System Disease Treatment Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Digestive System Disease Treatment Market Share by Region (2021-2026) Table 17. Global Digestive System Disease Treatment Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Digestive System Disease Treatment Market Share by Region (2027-2032) Table 19. Global Digestive System Disease Treatment Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Digestive System Disease Treatment Revenue Market Share by Players (2021-2026) Table 21. Global Digestive System Disease Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Digestive System Disease Treatment Key Players Headquarters & Area Served Table 23. Global Digestive System Disease Treatment Players, Product Type & Application Table 24. Global Digestive System Disease Treatment Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Digestive System Disease Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Digestive System Disease Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Digestive System Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Digestive System Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Digestive System Disease Treatment Revenue Market Share by Type (2021-2026) Table 31. Global Digestive System Disease Treatment Revenue Market Share by Type (2027-2032) Table 32. Global Digestive System Disease Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Digestive System Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Digestive System Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Digestive System Disease Treatment Revenue Market Share by Application (2021-2026) Table 36. Global Digestive System Disease Treatment Revenue Market Share by Application (2027-2032) Table 37. Zhengdatianqing Pharma Company Information Table 38. Zhengdatianqing Pharma Business Overview Table 39. Zhengdatianqing Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Zhengdatianqing Pharma Digestive System Disease Treatment Product Portfolio Table 41. Zhengdatianqing Pharma Recent Development Table 42. Takeda Pharma Company Information Table 43. Takeda Pharma Business Overview Table 44. Takeda Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Takeda Pharma Digestive System Disease Treatment Product Portfolio Table 46. Takeda Pharma Recent Development Table 47. Eisai Co. Company Information Table 48. Eisai Co. Business Overview Table 49. Eisai Co. Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Eisai Co. Digestive System Disease Treatment Product Portfolio Table 51. Eisai Co. Recent Development Table 52. Teva Company Information Table 53. Teva Business Overview Table 54. Teva Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Teva Digestive System Disease Treatment Product Portfolio Table 56. Teva Recent Development Table 57. Sun Pharma Company Information Table 58. Sun Pharma Business Overview Table 59. Sun Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Sun Pharma Digestive System Disease Treatment Product Portfolio Table 61. Sun Pharma Recent Development Table 62. Shanghai Shangyao Company Information Table 63. Shanghai Shangyao Business Overview Table 64. Shanghai Shangyao Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Shanghai Shangyao Digestive System Disease Treatment Product Portfolio Table 66. Shanghai Shangyao Recent Development Table 67. Sanofi Company Information Table 68. Sanofi Business Overview Table 69. Sanofi Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Sanofi Digestive System Disease Treatment Product Portfolio Table 71. Sanofi Recent Development Table 72. Luoxin Pharma Company Information Table 73. Luoxin Pharma Business Overview Table 74. Luoxin Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Luoxin Pharma Digestive System Disease Treatment Product Portfolio Table 76. Luoxin Pharma Recent Development Table 77. LIVZON Company Information Table 78. LIVZON Business Overview Table 79. LIVZON Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. LIVZON Digestive System Disease Treatment Product Portfolio Table 81. LIVZON Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Pfizer Digestive System Disease Treatment Product Portfolio Table 86. Pfizer Recent Development Table 87. Eastchina Pharma Company Information Table 88. Eastchina Pharma Business Overview Table 89. Eastchina Pharma Digestive System Disease Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Eastchina Pharma Digestive System Disease Treatment Product Portfolio Table 91. Eastchina Pharma Recent Development Table 92. Bayer Company Information Table 93. Bayer Business Overview Table 94. Bayer Digestive System Disease Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Bayer Digestive System Disease Treatment Product Portfolio Table 96. Bayer Recent Development Table 97. AbbVie Company Information Table 98. AbbVie Business Overview Table 99. AbbVie Digestive System Disease Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. AbbVie Digestive System Disease Treatment Product Portfolio Table 101. AbbVie Recent Development Table 102. AstraZeneca Company Information Table 103. AstraZeneca Business Overview Table 104. AstraZeneca Digestive System Disease Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. AstraZeneca Digestive System Disease Treatment Product Portfolio Table 106. AstraZeneca Recent Development Table 107. Zydus Cadila Company Information Table 108. Zydus Cadila Business Overview Table 109. Zydus Cadila Digestive System Disease Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Zydus Cadila Digestive System Disease Treatment Product Portfolio Table 111. Zydus Cadila Recent Development Table 112. Viatris Company Information Table 113. Viatris Business Overview Table 114. Viatris Digestive System Disease Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Viatris Digestive System Disease Treatment Product Portfolio Table 116. Viatris Recent Development Table 117. Intercept Company Information Table 118. Intercept Business Overview Table 119. Intercept Digestive System Disease Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Intercept Digestive System Disease Treatment Product Portfolio Table 121. Intercept Recent Development Table 122. Heron Therapeutics Company Information Table 123. Heron Therapeutics Business Overview Table 124. Heron Therapeutics Digestive System Disease Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Heron Therapeutics Digestive System Disease Treatment Product Portfolio Table 126. Heron Therapeutics Recent Development Table 127. Dr Falk Pharma Company Information Table 128. Dr Falk Pharma Business Overview Table 129. Dr Falk Pharma Digestive System Disease Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Dr Falk Pharma Digestive System Disease Treatment Product Portfolio Table 131. Dr Falk Pharma Recent Development Table 132. Bausch Health Company Information Table 133. Bausch Health Business Overview Table 134. Bausch Health Digestive System Disease Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Bausch Health Digestive System Disease Treatment Product Portfolio Table 136. Bausch Health Recent Development Table 137. AOSAIKANG Pharma Company Information Table 138. AOSAIKANG Pharma Business Overview Table 139. AOSAIKANG Pharma Digestive System Disease Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. AOSAIKANG Pharma Digestive System Disease Treatment Product Portfolio Table 141. AOSAIKANG Pharma Recent Development Table 142. North America Digestive System Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 143. North America Digestive System Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 144. North America Digestive System Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 145. North America Digestive System Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 146. North America Digestive System Disease Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. North America Digestive System Disease Treatment Revenue by Country (2021-2026) & (US$ Million) Table 148. North America Digestive System Disease Treatment Revenue by Country (US$ Million) & (2027-2032) Table 149. Europe Digestive System Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 150. Europe Digestive System Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 151. Europe Digestive System Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Digestive System Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Digestive System Disease Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Europe Digestive System Disease Treatment Revenue by Country (2021-2026) & (US$ Million) Table 155. Europe Digestive System Disease Treatment Revenue by Country (US$ Million) & (2027-2032) Table 156. China Digestive System Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 157. China Digestive System Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 158. China Digestive System Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 159. China Digestive System Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Digestive System Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 161. Asia Digestive System Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 162. Asia Digestive System Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia Digestive System Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia Digestive System Disease Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Digestive System Disease Treatment Revenue by Region (US$ Million) & (2021-2026) Table 166. Asia Digestive System Disease Treatment Revenue by Region (US$ Million) & (2027-2032) Table 167. SAMEA Digestive System Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 168. SAMEA Digestive System Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 169. SAMEA Digestive System Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA Digestive System Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA Digestive System Disease Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. SAMEA Digestive System Disease Treatment Revenue by Country (2021-2026) & (US$ Million) Table 173. SAMEA Digestive System Disease Treatment Revenue by Country (US$ Million) & (2027-2032) Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Digestive System Disease Treatment Image Figure 2. Global Digestive System Disease Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digestive System Disease Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. Tablet Image Figure 6. Caspuse Image Figure 7. Other Image Figure 8. Global Digestive System Disease Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Digestive System Disease Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Retail Pharmacy Image Figure 12. Other Image Figure 13. Global Digestive System Disease Treatment Market Size (US$ Million) & (2021-2032) Figure 14. Global Digestive System Disease Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Digestive System Disease Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Digestive System Disease Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Digestive System Disease Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Digestive System Disease Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Digestive System Disease Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global Digestive System Disease Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Digestive System Disease Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Digestive System Disease Treatment Revenue Market Share by Application (2021-2032) Figure 24. North America Digestive System Disease Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Digestive System Disease Treatment Revenue Share by Type (2021-2032) Figure 26. North America Digestive System Disease Treatment Revenue Share by Application (2021-2032) Figure 27. North America Digestive System Disease Treatment Revenue Share by Country (2021-2032) Figure 28. United States Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Digestive System Disease Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Digestive System Disease Treatment Revenue Share by Type (2021-2032) Figure 33. Europe Digestive System Disease Treatment Revenue Share by Application (2021-2032) Figure 34. Europe Digestive System Disease Treatment Revenue Share by Country (2021-2032) Figure 35. Germany Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Digestive System Disease Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Digestive System Disease Treatment Revenue Share by Type (2021-2032) Figure 45. China Digestive System Disease Treatment Revenue Share by Application (2021-2032) Figure 46. Asia Digestive System Disease Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Digestive System Disease Treatment Revenue Share by Type (2021-2032) Figure 48. Asia Digestive System Disease Treatment Revenue Share by Application (2021-2032) Figure 49. Asia Digestive System Disease Treatment Revenue Share by Region (2021-2032) Figure 50. Japan Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Digestive System Disease Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Digestive System Disease Treatment Revenue Share by Type (2021-2032) Figure 58. SAMEA Digestive System Disease Treatment Revenue Share by Application (2021-2032) Figure 59. SAMEA Digestive System Disease Treatment Revenue Share by Country (2021-2032) Figure 60. Brazil Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Digestive System Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablet
  • Caspuse
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Zhengdatianqing Pharma
  • Takeda Pharma
  • Eisai Co.
  • Teva
  • Sun Pharma
  • Shanghai Shangyao
  • Sanofi
  • Luoxin Pharma
  • LIVZON
  • Pfizer
  • Eastchina Pharma
  • Bayer
  • AbbVie
  • AstraZeneca
  • Zydus Cadila
  • Viatris
  • Intercept
  • Heron Therapeutics
  • Dr Falk Pharma
  • Bausch Health
  • AOSAIKANG Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Digestive System Disease Treatment Market by Type
  3. 1.2.1 Global Digestive System Disease Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Tablet
  6. 1.2.4 Caspuse
  7. 1.2.5 Other
  8. 1.3 Digestive System Disease Treatment Market by Application
  9. 1.3.1 Global Digestive System Disease Treatment Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Retail Pharmacy
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Digestive System Disease Treatment Market Dynamics
  1. 2.1 Digestive System Disease Treatment Industry Trends
  2. 2.2 Digestive System Disease Treatment Industry Drivers
  3. 2.3 Digestive System Disease Treatment Industry Opportunities and Challenges
  4. 2.4 Digestive System Disease Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Digestive System Disease Treatment Market Perspective (2021-2032)
  2. 3.2 Global Digestive System Disease Treatment Growth Trends by Region
  3. 3.2.1 Global Digestive System Disease Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Digestive System Disease Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Digestive System Disease Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Digestive System Disease Treatment Revenue by Players
  2. 4.1.1 Global Digestive System Disease Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Digestive System Disease Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Digestive System Disease Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Digestive System Disease Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Digestive System Disease Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Digestive System Disease Treatment Players, Product Type & Application
  8. 4.5 Global Digestive System Disease Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Digestive System Disease Treatment Market CR5 and HHI
  11. 4.6.3 2025 Digestive System Disease Treatment Tier 1, Tier 2, and Tier 3
5 Digestive System Disease Treatment Market Size by Type
  1. 5.1 Global Digestive System Disease Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Digestive System Disease Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Digestive System Disease Treatment Revenue Market Share by Type (2021-2032)
6 Digestive System Disease Treatment Market Size by Application
  1. 6.1 Global Digestive System Disease Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Digestive System Disease Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Digestive System Disease Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Zhengdatianqing Pharma
  2. 7.1.1 Zhengdatianqing Pharma Company Information
  3. 7.1.2 Zhengdatianqing Pharma Business Overview
  4. 7.1.3 Zhengdatianqing Pharma Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Zhengdatianqing Pharma Digestive System Disease Treatment Product Portfolio
  6. 7.1.5 Zhengdatianqing Pharma Recent Developments
  7. 7.2 Takeda Pharma
  8. 7.2.1 Takeda Pharma Company Information
  9. 7.2.2 Takeda Pharma Business Overview
  10. 7.2.3 Takeda Pharma Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Takeda Pharma Digestive System Disease Treatment Product Portfolio
  12. 7.2.5 Takeda Pharma Recent Developments
  13. 7.3 Eisai Co.
  14. 7.3.1 Eisai Co. Company Information
  15. 7.3.2 Eisai Co. Business Overview
  16. 7.3.3 Eisai Co. Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Eisai Co. Digestive System Disease Treatment Product Portfolio
  18. 7.3.5 Eisai Co. Recent Developments
  19. 7.4 Teva
  20. 7.4.1 Teva Company Information
  21. 7.4.2 Teva Business Overview
  22. 7.4.3 Teva Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Teva Digestive System Disease Treatment Product Portfolio
  24. 7.4.5 Teva Recent Developments
  25. 7.5 Sun Pharma
  26. 7.5.1 Sun Pharma Company Information
  27. 7.5.2 Sun Pharma Business Overview
  28. 7.5.3 Sun Pharma Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Sun Pharma Digestive System Disease Treatment Product Portfolio
  30. 7.5.5 Sun Pharma Recent Developments
  31. 7.6 Shanghai Shangyao
  32. 7.6.1 Shanghai Shangyao Company Information
  33. 7.6.2 Shanghai Shangyao Business Overview
  34. 7.6.3 Shanghai Shangyao Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Shanghai Shangyao Digestive System Disease Treatment Product Portfolio
  36. 7.6.5 Shanghai Shangyao Recent Developments
  37. 7.7 Sanofi
  38. 7.7.1 Sanofi Company Information
  39. 7.7.2 Sanofi Business Overview
  40. 7.7.3 Sanofi Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sanofi Digestive System Disease Treatment Product Portfolio
  42. 7.7.5 Sanofi Recent Developments
  43. 7.8 Luoxin Pharma
  44. 7.8.1 Luoxin Pharma Company Information
  45. 7.8.2 Luoxin Pharma Business Overview
  46. 7.8.3 Luoxin Pharma Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Luoxin Pharma Digestive System Disease Treatment Product Portfolio
  48. 7.8.5 Luoxin Pharma Recent Developments
  49. 7.9 LIVZON
  50. 7.9.1 LIVZON Company Information
  51. 7.9.2 LIVZON Business Overview
  52. 7.9.3 LIVZON Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 LIVZON Digestive System Disease Treatment Product Portfolio
  54. 7.9.5 LIVZON Recent Developments
  55. 7.10 Pfizer
  56. 7.10.1 Pfizer Company Information
  57. 7.10.2 Pfizer Business Overview
  58. 7.10.3 Pfizer Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Pfizer Digestive System Disease Treatment Product Portfolio
  60. 7.10.5 Pfizer Recent Developments
  61. 7.11 Eastchina Pharma
  62. 7.11.1 Eastchina Pharma Company Information
  63. 7.11.2 Eastchina Pharma Business Overview
  64. 7.11.3 Eastchina Pharma Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Eastchina Pharma Digestive System Disease Treatment Product Portfolio
  66. 7.11.5 Eastchina Pharma Recent Developments
  67. 7.12 Bayer
  68. 7.12.1 Bayer Company Information
  69. 7.12.2 Bayer Business Overview
  70. 7.12.3 Bayer Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Bayer Digestive System Disease Treatment Product Portfolio
  72. 7.12.5 Bayer Recent Developments
  73. 7.13 AbbVie
  74. 7.13.1 AbbVie Company Information
  75. 7.13.2 AbbVie Business Overview
  76. 7.13.3 AbbVie Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  77. 7.13.4 AbbVie Digestive System Disease Treatment Product Portfolio
  78. 7.13.5 AbbVie Recent Developments
  79. 7.14 AstraZeneca
  80. 7.14.1 AstraZeneca Company Information
  81. 7.14.2 AstraZeneca Business Overview
  82. 7.14.3 AstraZeneca Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  83. 7.14.4 AstraZeneca Digestive System Disease Treatment Product Portfolio
  84. 7.14.5 AstraZeneca Recent Developments
  85. 7.15 Zydus Cadila
  86. 7.15.1 Zydus Cadila Company Information
  87. 7.15.2 Zydus Cadila Business Overview
  88. 7.15.3 Zydus Cadila Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Zydus Cadila Digestive System Disease Treatment Product Portfolio
  90. 7.15.5 Zydus Cadila Recent Developments
  91. 7.16 Viatris
  92. 7.16.1 Viatris Company Information
  93. 7.16.2 Viatris Business Overview
  94. 7.16.3 Viatris Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Viatris Digestive System Disease Treatment Product Portfolio
  96. 7.16.5 Viatris Recent Developments
  97. 7.17 Intercept
  98. 7.17.1 Intercept Company Information
  99. 7.17.2 Intercept Business Overview
  100. 7.17.3 Intercept Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Intercept Digestive System Disease Treatment Product Portfolio
  102. 7.17.5 Intercept Recent Developments
  103. 7.18 Heron Therapeutics
  104. 7.18.1 Heron Therapeutics Company Information
  105. 7.18.2 Heron Therapeutics Business Overview
  106. 7.18.3 Heron Therapeutics Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Heron Therapeutics Digestive System Disease Treatment Product Portfolio
  108. 7.18.5 Heron Therapeutics Recent Developments
  109. 7.19 Dr Falk Pharma
  110. 7.19.1 Dr Falk Pharma Company Information
  111. 7.19.2 Dr Falk Pharma Business Overview
  112. 7.19.3 Dr Falk Pharma Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Dr Falk Pharma Digestive System Disease Treatment Product Portfolio
  114. 7.19.5 Dr Falk Pharma Recent Developments
  115. 7.20 Bausch Health
  116. 7.20.1 Bausch Health Company Information
  117. 7.20.2 Bausch Health Business Overview
  118. 7.20.3 Bausch Health Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Bausch Health Digestive System Disease Treatment Product Portfolio
  120. 7.20.5 Bausch Health Recent Developments
  121. 7.21 AOSAIKANG Pharma
  122. 7.21.1 AOSAIKANG Pharma Company Information
  123. 7.21.2 AOSAIKANG Pharma Business Overview
  124. 7.21.3 AOSAIKANG Pharma Digestive System Disease Treatment Revenue and Gross Margin (2021-2026)
  125. 7.21.4 AOSAIKANG Pharma Digestive System Disease Treatment Product Portfolio
  126. 7.21.5 AOSAIKANG Pharma Recent Developments
8 North America
  1. 8.1 North America Digestive System Disease Treatment Revenue (2021-2032)
  2. 8.2 North America Digestive System Disease Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Digestive System Disease Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Digestive System Disease Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Digestive System Disease Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Digestive System Disease Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Digestive System Disease Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Digestive System Disease Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Digestive System Disease Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Digestive System Disease Treatment Revenue by Country
  11. 8.6.1 North America Digestive System Disease Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Digestive System Disease Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Digestive System Disease Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Digestive System Disease Treatment Revenue (2021-2032)
  2. 9.2 Europe Digestive System Disease Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Digestive System Disease Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Digestive System Disease Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Digestive System Disease Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Digestive System Disease Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Digestive System Disease Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Digestive System Disease Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Digestive System Disease Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Digestive System Disease Treatment Revenue by Country
  11. 9.6.1 Europe Digestive System Disease Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Digestive System Disease Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Digestive System Disease Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Digestive System Disease Treatment Revenue (2021-2032)
  2. 10.2 China Digestive System Disease Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Digestive System Disease Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Digestive System Disease Treatment Revenue by Type (2027-2032)
  5. 10.3 China Digestive System Disease Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Digestive System Disease Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Digestive System Disease Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Digestive System Disease Treatment Revenue by Application (2027-2032)
  9. 10.5 China Digestive System Disease Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Digestive System Disease Treatment Revenue (2021-2032)
  2. 11.2 Asia Digestive System Disease Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Digestive System Disease Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Digestive System Disease Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Digestive System Disease Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Digestive System Disease Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Digestive System Disease Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Digestive System Disease Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Digestive System Disease Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Digestive System Disease Treatment Revenue by Country
  11. 11.6.1 Asia Digestive System Disease Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Digestive System Disease Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Digestive System Disease Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Digestive System Disease Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Digestive System Disease Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Digestive System Disease Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Digestive System Disease Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Digestive System Disease Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Digestive System Disease Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Digestive System Disease Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Digestive System Disease Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Digestive System Disease Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Digestive System Disease Treatment Revenue by Country
  11. 12.6.1 SAMEA Digestive System Disease Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Digestive System Disease Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Digestive System Disease Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst